The Supreme Court unanimously ruled in FDA v. Alliance for Hippocratic Medicine that the plaintiffs lacked a legal right to challenge the health agency’s actions regarding the approval of abortion pill mifepristone.
New dark money group ads emerge in Chinese biotech legislation fight
Ads from a group dubbed “Defend Our DNA” have emerged as lawmakers in debate legislation that would restrict federal business with certain Chinese biotechs.
DOJ proposal to reclassify cannabis sparks hope for legalization
The Biden administration’s final rule prohibits the disclosure of protected health information to law enforcement when it comes to patients seeking abortions in other states.
Nearly 80% of Americans want stricter AI regulations. Where does the U.S. stand?
Former president Donald Trump said this week he did not support a federal abortion ban, and that abortion rights should be left to the states to decide instead.
‘We beat Big Pharma’: President Biden, Bernie Sanders tout drug pricing reform
President Joe Biden and Sen. Bernie Sanders teamed up to push more efforts on drug pricing reform, including lowering the out-of-pocket cost of inhalers.
What the Supreme Court’s mifepristone hearing could mean for pharma
Anti-abortion plaintiffs argued against the FDA’s expanded access to the abortion pill in a case that could have significant implications for the pharma industry.
AI Deciphered: Discovering the Potential for Marketers and Communicators